Emilio Cordova

Chief Executive Officer at SAMDI Tech, Inc.

Commercial Services

Health Technology

Profile

Emilio Cordova is currently the Chief Executive Officer at SAMDI Tech, Inc. since 2015.
Prior to this, he worked as the Vice President-Business Development at Inotiv, Inc.

Emilio Cordova active positions

Companies	Position	Start
SAMDI Tech, Inc. SAMDI Tech, Inc. BiotechnologyHealth Technology Part of Charles River Laboratories International, Inc., SAMDI Tech, Inc. delivers better, faster assay development, high-throughput screening and hit-to-lead solutions for early-stage drug discovery. The company is based in Chicago, IL. Our highly skilled team of biochemistry experts believes in quality results and uses proprietary industry-leading, label-free SAMDI (Self-Assembled Monolayer Desorption Ionization) technology to deliver decision-making data for diverse targets and analytes. SAMDI Tech offers label-free drug discovery solutions for better, faster results. The company was founded by Michael Scholle, Milan Mrksich. Emilio Cordova has been the CEO of the company since 2015. SAMDI Tech was acquired by Charles River Laboratories International, Inc. on January 30, 2023 for $50 million.	Chief Executive Officer	01/01/2015

All active positions of Emilio Cordova

Former positions of Emilio Cordova

Companies	Position	End
INOTIV, INC.	Corporate Officer/Principal	01/10/2008

See the detail of Emilio Cordova's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Emilio Cordova's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
INOTIV, INC.	Commercial Services

Private companies	1
SAMDI Tech, Inc. SAMDI Tech, Inc. BiotechnologyHealth Technology Part of Charles River Laboratories International, Inc., SAMDI Tech, Inc. delivers better, faster assay development, high-throughput screening and hit-to-lead solutions for early-stage drug discovery. The company is based in Chicago, IL. Our highly skilled team of biochemistry experts believes in quality results and uses proprietary industry-leading, label-free SAMDI (Self-Assembled Monolayer Desorption Ionization) technology to deliver decision-making data for diverse targets and analytes. SAMDI Tech offers label-free drug discovery solutions for better, faster results. The company was founded by Michael Scholle, Milan Mrksich. Emilio Cordova has been the CEO of the company since 2015. SAMDI Tech was acquired by Charles River Laboratories International, Inc. on January 30, 2023 for $50 million.	Health Technology